Effects of differing nicotine-replacement doses on weight gain after smoking cessation.

S. J. Leischow, D. P. Sachs, A. G. Bostrom, M. D. Hansen

Research output: Contribution to journalArticle

Abstract

OBJECTIVE: To prospectively assess effects of doses of a nicotine-replacement agent on weight gain in men and women after smoking cessation. DESIGN: Four-week, randomized, double-blind clinical trial. SETTING: Outpatient medical clinic. STUDY PARTICIPANTS: Healthy volunteers who smoked at least 10 cigarettes per day. INTERVENTION: Pharmacologic: Random assignment to 0, 2, or 4 mg of nicotine polacrilex on a fixed-dose schedule (one piece per hour while awake). Behavioral: Brief, medical/behavioral counseling regarding smoking cessation. MAIN OUTCOME MEASURE: Weight change as a function of dose and gender only in participants abstinent for all 4 week. (Self-reported abstinence verified by breath carbon monoxide levels). RESULTS: Weight change in women abstinent for 4 weeks (n = 16) was +1.69, +0.33, and -0.26 kg in the placebo, 2-mg, and 4-mg groups, respectively, compared with +1.60, +1.45, and +1.18 kg for the men who were abstinent for 4 weeks (n = 19). Medication use did not differ as a function of dose or gender. CONCLUSIONS: Nicotine polacrilex suppressed, in a dose-related fashion, weight gain after smoking cessation in successfully treated women. Weight gain was not shown to be suppressed in men, possibly because of small sample size.

Original languageEnglish (US)
Pages (from-to)233-237
Number of pages5
JournalArchives of Family Medicine
Volume1
Issue number2
StatePublished - Nov 1992
Externally publishedYes

Fingerprint

Smoking Cessation
Nicotine
Tobacco Use Cessation Products
Weight Gain
Weights and Measures
Carbon Monoxide
Ambulatory Care Facilities
Tobacco Products
Sample Size
Counseling
Appointments and Schedules
Healthy Volunteers
Placebos
Clinical Trials

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Leischow, S. J., Sachs, D. P., Bostrom, A. G., & Hansen, M. D. (1992). Effects of differing nicotine-replacement doses on weight gain after smoking cessation. Archives of Family Medicine, 1(2), 233-237.

Effects of differing nicotine-replacement doses on weight gain after smoking cessation. / Leischow, S. J.; Sachs, D. P.; Bostrom, A. G.; Hansen, M. D.

In: Archives of Family Medicine, Vol. 1, No. 2, 11.1992, p. 233-237.

Research output: Contribution to journalArticle

Leischow, SJ, Sachs, DP, Bostrom, AG & Hansen, MD 1992, 'Effects of differing nicotine-replacement doses on weight gain after smoking cessation.', Archives of Family Medicine, vol. 1, no. 2, pp. 233-237.
Leischow, S. J. ; Sachs, D. P. ; Bostrom, A. G. ; Hansen, M. D. / Effects of differing nicotine-replacement doses on weight gain after smoking cessation. In: Archives of Family Medicine. 1992 ; Vol. 1, No. 2. pp. 233-237.
@article{8229498d6d644578b431e7d04475ef70,
title = "Effects of differing nicotine-replacement doses on weight gain after smoking cessation.",
abstract = "OBJECTIVE: To prospectively assess effects of doses of a nicotine-replacement agent on weight gain in men and women after smoking cessation. DESIGN: Four-week, randomized, double-blind clinical trial. SETTING: Outpatient medical clinic. STUDY PARTICIPANTS: Healthy volunteers who smoked at least 10 cigarettes per day. INTERVENTION: Pharmacologic: Random assignment to 0, 2, or 4 mg of nicotine polacrilex on a fixed-dose schedule (one piece per hour while awake). Behavioral: Brief, medical/behavioral counseling regarding smoking cessation. MAIN OUTCOME MEASURE: Weight change as a function of dose and gender only in participants abstinent for all 4 week. (Self-reported abstinence verified by breath carbon monoxide levels). RESULTS: Weight change in women abstinent for 4 weeks (n = 16) was +1.69, +0.33, and -0.26 kg in the placebo, 2-mg, and 4-mg groups, respectively, compared with +1.60, +1.45, and +1.18 kg for the men who were abstinent for 4 weeks (n = 19). Medication use did not differ as a function of dose or gender. CONCLUSIONS: Nicotine polacrilex suppressed, in a dose-related fashion, weight gain after smoking cessation in successfully treated women. Weight gain was not shown to be suppressed in men, possibly because of small sample size.",
author = "Leischow, {S. J.} and Sachs, {D. P.} and Bostrom, {A. G.} and Hansen, {M. D.}",
year = "1992",
month = "11",
language = "English (US)",
volume = "1",
pages = "233--237",
journal = "Archives of Family Medicine",
issn = "1063-3987",
publisher = "American Medical Association",
number = "2",

}

TY - JOUR

T1 - Effects of differing nicotine-replacement doses on weight gain after smoking cessation.

AU - Leischow, S. J.

AU - Sachs, D. P.

AU - Bostrom, A. G.

AU - Hansen, M. D.

PY - 1992/11

Y1 - 1992/11

N2 - OBJECTIVE: To prospectively assess effects of doses of a nicotine-replacement agent on weight gain in men and women after smoking cessation. DESIGN: Four-week, randomized, double-blind clinical trial. SETTING: Outpatient medical clinic. STUDY PARTICIPANTS: Healthy volunteers who smoked at least 10 cigarettes per day. INTERVENTION: Pharmacologic: Random assignment to 0, 2, or 4 mg of nicotine polacrilex on a fixed-dose schedule (one piece per hour while awake). Behavioral: Brief, medical/behavioral counseling regarding smoking cessation. MAIN OUTCOME MEASURE: Weight change as a function of dose and gender only in participants abstinent for all 4 week. (Self-reported abstinence verified by breath carbon monoxide levels). RESULTS: Weight change in women abstinent for 4 weeks (n = 16) was +1.69, +0.33, and -0.26 kg in the placebo, 2-mg, and 4-mg groups, respectively, compared with +1.60, +1.45, and +1.18 kg for the men who were abstinent for 4 weeks (n = 19). Medication use did not differ as a function of dose or gender. CONCLUSIONS: Nicotine polacrilex suppressed, in a dose-related fashion, weight gain after smoking cessation in successfully treated women. Weight gain was not shown to be suppressed in men, possibly because of small sample size.

AB - OBJECTIVE: To prospectively assess effects of doses of a nicotine-replacement agent on weight gain in men and women after smoking cessation. DESIGN: Four-week, randomized, double-blind clinical trial. SETTING: Outpatient medical clinic. STUDY PARTICIPANTS: Healthy volunteers who smoked at least 10 cigarettes per day. INTERVENTION: Pharmacologic: Random assignment to 0, 2, or 4 mg of nicotine polacrilex on a fixed-dose schedule (one piece per hour while awake). Behavioral: Brief, medical/behavioral counseling regarding smoking cessation. MAIN OUTCOME MEASURE: Weight change as a function of dose and gender only in participants abstinent for all 4 week. (Self-reported abstinence verified by breath carbon monoxide levels). RESULTS: Weight change in women abstinent for 4 weeks (n = 16) was +1.69, +0.33, and -0.26 kg in the placebo, 2-mg, and 4-mg groups, respectively, compared with +1.60, +1.45, and +1.18 kg for the men who were abstinent for 4 weeks (n = 19). Medication use did not differ as a function of dose or gender. CONCLUSIONS: Nicotine polacrilex suppressed, in a dose-related fashion, weight gain after smoking cessation in successfully treated women. Weight gain was not shown to be suppressed in men, possibly because of small sample size.

UR - http://www.scopus.com/inward/record.url?scp=0026942639&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026942639&partnerID=8YFLogxK

M3 - Article

C2 - 1341599

VL - 1

SP - 233

EP - 237

JO - Archives of Family Medicine

JF - Archives of Family Medicine

SN - 1063-3987

IS - 2

ER -